IRIS
BRACCI, LUISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.408
EU - Europa 11.953
AS - Asia 5.304
SA - Sud America 961
AF - Africa 109
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 11
Totale 32.772
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.266
GB - Regno Unito 2.776
RU - Federazione Russa 2.388
CN - Cina 2.201
SG - Singapore 1.533
IE - Irlanda 1.494
IT - Italia 1.393
SE - Svezia 955
UA - Ucraina 877
BR - Brasile 810
DE - Germania 808
FR - Francia 464
HK - Hong Kong 408
KR - Corea 341
FI - Finlandia 302
VN - Vietnam 278
ES - Italia 146
IN - India 140
CA - Canada 84
BE - Belgio 75
PL - Polonia 72
BD - Bangladesh 60
AR - Argentina 57
NL - Olanda 54
TR - Turchia 51
JP - Giappone 49
ZA - Sudafrica 36
PK - Pakistan 34
CZ - Repubblica Ceca 32
MX - Messico 31
IR - Iran 28
EC - Ecuador 26
AT - Austria 24
CI - Costa d'Avorio 24
IQ - Iraq 24
AU - Australia 20
ID - Indonesia 18
VE - Venezuela 16
AE - Emirati Arabi Uniti 15
IL - Israele 14
PH - Filippine 14
MA - Marocco 13
PE - Perù 13
UZ - Uzbekistan 13
CL - Cile 12
LT - Lituania 12
RO - Romania 12
SA - Arabia Saudita 12
EU - Europa 11
CO - Colombia 10
EG - Egitto 10
KE - Kenya 10
PY - Paraguay 10
AZ - Azerbaigian 9
CH - Svizzera 9
KG - Kirghizistan 8
KZ - Kazakistan 8
DK - Danimarca 7
EE - Estonia 7
JO - Giordania 7
RS - Serbia 7
BG - Bulgaria 6
BY - Bielorussia 6
LB - Libano 6
DZ - Algeria 5
JM - Giamaica 5
NZ - Nuova Zelanda 5
PA - Panama 5
AL - Albania 4
HU - Ungheria 4
LA - Repubblica Popolare Democratica del Laos 4
OM - Oman 4
AM - Armenia 3
BB - Barbados 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
MY - Malesia 3
NP - Nepal 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
TN - Tunisia 3
UY - Uruguay 3
BA - Bosnia-Erzegovina 2
BN - Brunei Darussalam 2
BO - Bolivia 2
ET - Etiopia 2
GE - Georgia 2
HN - Honduras 2
LK - Sri Lanka 2
LV - Lettonia 2
NO - Norvegia 2
SI - Slovenia 2
SN - Senegal 2
TH - Thailandia 2
BH - Bahrain 1
CM - Camerun 1
CY - Cipro 1
FJ - Figi 1
GD - Grenada 1
Totale 32.754
Salva come PNG Salva come JPEG
Città #
Southend 2.485
Dallas 1.795
Dublin 1.478
Fairfield 1.448
Ashburn 1.064
Chandler 875
Singapore 857
Menlo Park 839
Woodbridge 716
Jacksonville 709
Moscow 673
Santa Clara 609
Houston 570
Beijing 559
Seattle 551
Wilmington 523
Siena 499
Ann Arbor 492
Cambridge 447
Hong Kong 399
Hefei 352
Seoul 340
Princeton 272
Nanjing 216
Los Angeles 201
New York 191
Munich 146
Boardman 129
Helsinki 117
Málaga 113
San Mateo 109
Shanghai 104
The Dalles 99
Milan 93
Dong Ket 91
Nanchang 89
Buffalo 88
San Diego 82
São Paulo 80
Florence 75
Rome 64
Fremont 62
Council Bluffs 59
Hebei 59
Ho Chi Minh City 59
Shenyang 58
Brussels 56
Dearborn 53
London 50
Washington 48
Tianjin 47
Bengaluru 45
Warsaw 44
Hanoi 43
Turku 43
Chicago 42
Columbus 41
Redwood City 41
Kunming 39
Toronto 38
Brooklyn 37
Jiaxing 37
Jinan 33
Tokyo 33
Frankfurt am Main 31
Phoenix 31
Redondo Beach 31
Changsha 30
Düsseldorf 29
Izmir 29
Stockholm 29
Johannesburg 27
Lancaster 25
University Park 25
Abidjan 24
Denver 24
Rio de Janeiro 24
Zhengzhou 24
Atlanta 23
Brno 23
Chennai 23
Orem 22
Bagno a Ripoli 21
Dhaka 21
Hangzhou 21
San Francisco 21
Amsterdam 20
Guangzhou 20
Poplar 20
Belo Horizonte 19
Brasília 19
Lappeenranta 19
Nuremberg 19
Montreal 18
Venezia 17
Ningbo 15
Nürnberg 15
Tappahannock 15
Gdansk 14
Norwalk 14
Totale 22.508
Salva come PNG Salva come JPEG
Nome #
Near-infrared quantum dots labelled with a tumor selective tetrabranched peptide for in vivo imaging 352
Insights into the role of sulfated glycans in cancer cell adhesion and migration through use of branched peptide probe 342
The GAG-specific branched peptide NT4 reduces angiogenesis and invasiveness of tumor cells 341
Effect of ligand binding on human D-amino acid oxidase: implications for the development of new drugs for schizophrenia treatment 337
A monoclonal antibody to a synthetic fragment of rabies virus glycoprotein binds ligands of the nicotinic cholinergic receptor 333
Extremely potent human monoclonal antibodies from COVID-19 convalescent patients 323
Investigations into the killing activity of an antimicrobial peptide active against extensively antibiotic-resistant K. pneumoniae and P. aeruginosa 322
Heterologous Prime-Boost Combinations Highlight the Crucial Role of Adjuvant in Priming the Immune System 321
Antipeptide monoclonal antibodies inhibit the binding of rabiesvirus glycoprotein and alpha-bungarotoxin to the nicotinic acetylcholine receptor 320
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo. 306
Tumor-selective peptide-carrier delivery of Paclitaxel increases in vivo activity of the drug 304
Heparan sulfate proteoglycans can promote opposite effects on adhesion and directional migration of different cancer cells 299
11β-hydroxysteroid dehydrogenase expression in first trimester human trophoblasts 295
A model of the rabies virus glycoprotein active site 293
Antigenicity and immunogenicity of the V3 domain of HIV-1 gp120 expressed on the surface of Streptococcus gordonii. AIDS Res Hum Retroviruses 290
Cancer selectivity of tetrabranched neurotensin peptides is generated by simultaneous binding to sulfated glycosaminoglycans and protein receptors. 288
Anti-mu opioid antiserum against the third external loop of the cloned mu-opioid receptor acts as a mu receptor neutral antagonist 286
An antimicrobial molecule mitigates signs of sepsis in vivo and eradicates infections from lung tissue 286
Efficacy and toxicity of the antimicrobial peptide M33 produced with different counter-ions 280
A new NT4 peptide-based drug delivery system for cancer treatment 280
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo 279
Neurotensin branched peptide as a tumor-targeting agent for human bladder cancer 279
Peptides and small molecules blocking the CXCR4/CXCL12 axis overcome bone marrow-induced chemoresistance in acute leukemias 276
Unraveling Heparan Sulfate Proteoglycan Binding Motif for Cancer Cell Selectivity 272
Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project" 269
A novel phage-library-selected peptide inhibits human TNF-α binding to its receptors 264
High performance liquid chromatography immunoaffinity purification of antibodies and antibody fragments 259
In vitro and in vivo efficacy, toxicity, bio-distribution and resistance selection of a novel antibacterial drug candidate 258
Oxidative stress-induced apoptosis in peripheral blood lymphocytes from patients with POLG-related disorders 258
Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification. 257
Coupling to a cancer-selective heparan-sulfate-targeted branched peptide can by-pass breast cancer cell resistance to methotrexate 257
Isomerization of an Antimicrobial Peptide Broadens Antimicrobial Spectrum to Gram-Positive Bacterial Pathogens 257
Tumor imaging with tetrabranched neurotensin 251
Antimicrobial peptide-loaded nanoparticles as inhalation therapy for Pseudomonas aeruginosa infections 247
Site-specific pegylation of an antimicrobial peptide increases resistance to Pseudomonas aeruginosa elastase 246
Antibacterial and anti-inflammatory activity of an antimicrobial peptide synthesized with D amino acids 246
Supramolecular aggregates as drug carriers on cell expressing receptors for branched Neurotensin 245
Antimicrobial activity of levofloxacin - M33 peptide conjugation or combination 245
Analysis of the utility of a rapid vesicle isolation method for clinical strains of Pseudomonas aeruginosa 243
A branched peptide mimotope of the nicotinic receptor binding site is a potent synthetic antidote against the snake neurotoxin alpha-bungarotoxin 243
Affinity purification of rabies virus glycoprotein using immobilized antipeptide antibodies 242
HIV-1 gp 120 binding to nicotinig receptors 242
Branched peptides as bioactive molecules for drug design 239
Purification of acidic synthetic peptides by high performance liquid chromatography using ammonium acetate buffer 238
Branched Neurotensin For Tumor Targeting 233
Antibacterial peptides and analogues thereof 232
Structure of rubella E1 glycoprotein epitopes established by multiple peptide synthesis 231
Branched peptides for tumor diagnosis and therapy 229
Bioactive peptides from libraries 226
Modular Branched Neurotensin Peptides for Tumor Target Tracing and Receptor-Mediated Therapy: A Proof-of-Concept 226
Antibacterial and Anti-Inflammatory Activity of Branched Peptides Derived from Natural Host Defense Sequences 224
Toxin-related antibodies with antimicrobial and antiviral activity 224
An antigenic determinant common to human chorionic somatomammotropin and human growth hormone revealed by limited proteolysis of immune complexes 223
Anti-ganglioside antibodies in a large cohort of European patients with systemic lupus erythematosus: Clinical, serological, and HLA class II gene associations 223
Antigenicity of HIV-derived T-helper determinants in the context of carrier recombinant proteins: effect on T-helper cell repertoire selection 222
HIV-1 and human myelin proteins share an antigenic determinant 221
Antagonistic activity of HIV-1 T helper peptides flanked by an unrelated carrier protein 220
HPLC immunoaffinity purification of rabies virus glycoprotein using immobilized antipeptide antibodies 219
Nanoparticles exposing neurotensin tumor-specific drivers 219
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 217
Biochemical filtering of a protein-protein docking simulation identifies the structure of a complex between a recombinant antibody fragment and alpha-bungarotoxin 215
Branched peptides as targeting agents for tumor imaging and therapy 215
Endogenous morphine modulates acute thermonociception in mice 214
Characterization of immunoreactive octapeptides of human-cytomegalovirus gp58 213
Immunogenicity of a free synthetic peptide: carrier-conjugation enhances antibody affinity for the native protein 209
Proprietà di legame di anticorpi monoclonali contro il virus della rabbia ottenuti per mezzo di immunizzazione con un peptide sintetico 209
Dendrimeric peptide inhibitors of anthrax lethal and edema factors 209
Antimicrobial peptide, branched forms thereof, and their use in the treatment of bacterial infections 208
Mimicking the nicotinic receptor binding site by a single chain Fv selected by competitive panning from a synthetic phage library 207
Antimicrobial peptides active in in vitro models of endodontic bacterial infections modulate inflammation in human cardiac fibroblasts 206
Branched multimeric peptides for tumor diagnosis and therapy 206
Synthetic peptides in the form of dendrimers become resistant to protease activity 206
Branched Neurotensin peptides for tumor personalized therapy 204
Immunomodulatory and anti-inflammatory activity in vitro and in vivo of a novel antimicrobial candidate 202
Synthesis and biological activity of stable branched neurotensin peptides for tumor targeting 200
Exploiting Free-Energy Minima to Design Novel EphA2 Protein-Protein Antagonists: From Simulation to Experiment and Return 199
Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens 199
Targeting different LRP receptors and sulfated proteoglycan by branched neurotensin provide high cancer selectivity 198
Selective occlusion of tumor blood vessels by targeted delivery of an antibody-photosensitizer conjugate 197
Branched neurotensin for tumor targeting 197
The development of antimicrobial peptides as new antibacterial drugs 197
Analysis of opa1 isoforms expression and apoptosis regulation in autosomal dominant optic atrophy (ADOA) patients with mutations in the opa1 gene 196
Endocytosis and trafficking of heparan sulfate proteoglycans in triple-negative breast cancer cells unraveled with a polycationic peptide 195
Design and in vitro evaluation of branched peptide conjugates:turning nonspecific cytotoxic drugs into tumor-selective agents 193
The antimicrobial peptide M33. An example of drug development 190
Identification of a neutralizing epitope on tosv gn glycoprotein 188
Therapeutic activity of an engineered synthetic killer antiidiotypic antibody fragment against experimental mucosal and systemic candidiasis 187
Binding of HIV-1 gp120 to the nicotinic receptor 187
Determination of antigen-specific immunoglobulin content in ascitic fluids and antisera 187
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 187
Molecular basis of branched peptides resistance to enzyme proteolysis 187
Synthetic peptides of rubella E1 glycoprotein for serological assays 186
Mimotopes of the nicotinic receptor binding site selected by a combinatorial peptide library 185
Biochemical characterization and strong in vivo activity of a novel antimicrobial peptide specific for gram-negative bacteria 184
A novel mimetic antigen eliciting protective antibody to Neisseria Meningitidis 184
Three-dimensional computation of atom depth in complex molecular structures 181
Molecular definition of the interaction between a tumor-specific tetrabranched peptide and LRP6 receptor 181
NMR studies of lysozyme surface accessibility by using different paramagnetic relaxation probes 180
Tumor selective targeting by branched peptides 180
Peptide-protein interactions studied by surface plasmon and nuclear magnetic resonances 179
Totale 23.746
Salva come PNG Salva come JPEG
Categoria #
all - tutte 96.893
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 96.893
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.437 0 0 0 0 0 495 279 457 331 365 236 274
2021/20222.237 155 264 150 228 131 82 109 110 97 245 203 463
2022/20233.162 185 322 408 440 340 602 61 254 240 142 124 44
2023/20242.366 79 76 235 117 101 682 817 50 9 43 17 140
2024/20254.699 96 225 524 268 569 262 169 303 366 170 530 1.217
2025/20267.796 858 1.591 1.511 1.410 2.280 146 0 0 0 0 0 0
Totale 33.090